Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1541407
PUBLISHER: IMARC | PRODUCT CODE: 1541407
Bronchodilators Market Report by Indication (Asthma, Chronic Obstructive Pulmonary Disease, and Others), Drug Type, Route of Administration, and Region 2024-2032
PUBLISHED:
PAGES: 135 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global bronchodilators market size reached US$ 37.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 55.9 Billion by 2032, exhibiting a growth rate (CAGR) of 4.4% during 2024-2032.
Bronchodilators are medications used to treat patients suffering from long-term conditions of narrow and inflamed airways, such as asthma, emphysema, and chronic obstructive pulmonary disease (COPD). They help relieve associated symptoms by relaxing the muscles around the airways or bronchi, clearing mucus from the lungs, and making breathing easier. They are available in the form of tablets, liquid, nebulizer solutions, and metered-dose and dry powder inhalers. Nowadays, bronchodilators are also utilized to enhance the effect of inhaled corticosteroids, which act as a primary treatment to reduce inflammation and prevent flare-ups in asthma.
Bronchodilators Market Trends:
A significantly rising number of patients with acute respiratory infections due to coronavirus disease (COVID-19) represents one of the key factors influencing the need for bronchodilators across the globe. Apart from this, increasing levels of air pollution, the rising number of smokers, and the growing prevalence of infectious diseases around the world are contributing to the risk of developing lung conditions. This is acting as another growth-inducing factor of the market. In addition, lung function declines gradually with age, which can make breathing slightly difficult. This, along with the increasing geriatric population and a considerable rise in consumer spending capacities, is driving the market. Other factors, such as improving healthcare infrastructure and diagnostic modalities and rising shift towards non-invasive procedures, are also propelling the market growth. Furthermore, several new classes of bronchodilators that can help overcome the limitations of existing products are in the preclinical phase stage. In confluence with this, health agencies of numerous countries are supporting research and development (R&D) activities for bronchodilators, which is anticipated to create a positive outlook for the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global bronchodilators market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on indication, drug type and route of administration.
Breakup by Indication:
Asthma
Chronic Obstructive Pulmonary Disease (COPD)
Others
Breakup by Drug Type:
Sympathomimetics
Anticholinergics
Phosphodiesterase Inhibitor
Combination Drugs
Breakup by Route of Administration:
Oral
Injection
Inhaler
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AstraZeneca plc, Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Novartis AG, Pfizer Inc., Sanofi, Teva Pharmaceutical Industries Ltd. and Vectura Group plc.
Key Questions Answered in This Report
- 1. How big is the global bronchodilators market?
- 2. What is the expected growth rate of the global bronchodilators market during 2024-2032?
- 3. What are the key factors driving the global bronchodilators market?
- 4. What has been the impact of COVID-19 on the global bronchodilators market?
- 5. What is the breakup of the global bronchodilators market based on the indication?
- 6. What is the breakup of the global bronchodilators market based on the drug type?
- 7. What is the breakup of the global bronchodilators market based on the route of administration?
- 8. What are the key regions in the global bronchodilators market?
- 9. Who are the key players/companies in the global bronchodilators market?
Product Code: SR112024A4184
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Bronchodilators Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Indication
- 6.1 Asthma
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Chronic Obstructive Pulmonary Disease (COPD)
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Others
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Drug Type
- 7.1 Sympathomimetics
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Anticholinergics
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Phosphodiesterase Inhibitor
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Combination Drugs
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by Route of Administration
- 8.1 Oral
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Injection
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Inhaler
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Abbott Laboratories
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 AstraZeneca plc
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.2.4 SWOT Analysis
- 14.3.3 Boehringer Ingelheim International GmbH
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.4 F. Hoffmann-La Roche Ltd
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 SWOT Analysis
- 14.3.5 GlaxoSmithKline plc
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 Novartis AG
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 Pfizer Inc.
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 Sanofi
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Teva Pharmaceutical Industries Ltd.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 Vectura Group plc
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.1 Abbott Laboratories
Product Code: SR112024A4184
List of Figures
- Figure 1: Global: Bronchodilators Market: Major Drivers and Challenges
- Figure 2: Global: Bronchodilators Market: Sales Value (in Billion US$), 2018-2023
- Figure 3: Global: Bronchodilators Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 4: Global: Bronchodilators Market: Breakup by Indication (in %), 2023
- Figure 5: Global: Bronchodilators Market: Breakup by Drug Type (in %), 2023
- Figure 6: Global: Bronchodilators Market: Breakup by Route of Administration (in %), 2023
- Figure 7: Global: Bronchodilators Market: Breakup by Region (in %), 2023
- Figure 8: Global: Bronchodilators (Asthma) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 9: Global: Bronchodilators (Asthma) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 10: Global: Bronchodilators (Chronic Obstructive Pulmonary Disease - COPD) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 11: Global: Bronchodilators (Chronic Obstructive Pulmonary Disease - COPD) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 12: Global: Bronchodilators (Other Indications) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 13: Global: Bronchodilators (Other Indications) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 14: Global: Bronchodilators (Sympathomimetics) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 15: Global: Bronchodilators (Sympathomimetics) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 16: Global: Bronchodilators (Anticholinergics) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 17: Global: Bronchodilators (Anticholinergics) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 18: Global: Bronchodilators (Phosphodiesterase Inhibitor) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 19: Global: Bronchodilators (Phosphodiesterase Inhibitor) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 20: Global: Bronchodilators (Combination Drugs) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 21: Global: Bronchodilators (Combination Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 22: Global: Bronchodilators (Oral) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 23: Global: Bronchodilators (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 24: Global: Bronchodilators (Injection) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 25: Global: Bronchodilators (Injection) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 26: Global: Bronchodilators (Inhaler) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 27: Global: Bronchodilators (Inhaler) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 28: North America: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 29: North America: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 30: United States: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 31: United States: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 32: Canada: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 33: Canada: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 34: Asia-Pacific: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 35: Asia-Pacific: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 36: China: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 37: China: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 38: Japan: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 39: Japan: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 40: India: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 41: India: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 42: South Korea: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 43: South Korea: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 44: Australia: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 45: Australia: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 46: Indonesia: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 47: Indonesia: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 48: Others: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 49: Others: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 50: Europe: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 51: Europe: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 52: Germany: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 53: Germany: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 54: France: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 55: France: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 56: United Kingdom: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 57: United Kingdom: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 58: Italy: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 59: Italy: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 60: Spain: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 61: Spain: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 62: Russia: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 63: Russia: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 64: Others: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 65: Others: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 66: Latin America: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 67: Latin America: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 68: Brazil: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 69: Brazil: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 70: Mexico: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 71: Mexico: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 72: Others: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 73: Others: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 74: Middle East and Africa: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 75: Middle East and Africa: Bronchodilators Market: Breakup by Country (in %), 2023
- Figure 76: Middle East and Africa: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 77: Global: Bronchodilators Industry: SWOT Analysis
- Figure 78: Global: Bronchodilators Industry: Value Chain Analysis
- Figure 79: Global: Bronchodilators Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Bronchodilators Market: Key Industry Highlights, 2023 and 2032
- Table 2: Global: Bronchodilators Market Forecast: Breakup by Indication (in Million US$), 2024-2032
- Table 3: Global: Bronchodilators Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
- Table 4: Global: Bronchodilators Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
- Table 5: Global: Bronchodilators Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 6: Global: Bronchodilators Market: Competitive Structure
- Table 7: Global: Bronchodilators Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.